251 related articles for article (PubMed ID: 3239743)
1. High-performance liquid chromatographic analysis of 32P-postlabeled DNA-aromatic carcinogen adducts.
Levy GN; Weber WW
Anal Biochem; 1988 Nov; 174(2):381-92. PubMed ID: 3239743
[TBL] [Abstract][Full Text] [Related]
2. HPLC enrichment of hydrophobic DNA--carcinogen adducts for enhanced sensitivity of 32P-postlabeling analysis.
Dunn BP; San RH
Carcinogenesis; 1988 Jun; 9(6):1055-60. PubMed ID: 3286027
[TBL] [Abstract][Full Text] [Related]
3. 2-Aminofluorene-DNA adducts in mouse urinary bladder: effect of age, sex and acetylator phenotype.
Levy GN; Weber WW
Carcinogenesis; 1992 Feb; 13(2):159-64. PubMed ID: 1740004
[TBL] [Abstract][Full Text] [Related]
4. Immunochemical, 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation.
Culp SJ; Roberts DW; Talaska G; Lang NP; Fu PP; Lay JO; Teitel CH; Snawder JE; Von Tungeln LS; Kadlubar FF
Mutat Res; 1997 Aug; 378(1-2):97-112. PubMed ID: 9288889
[TBL] [Abstract][Full Text] [Related]
5. Improved high-performance liquid chromatography analysis of 32P-postlabeled 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-DNA adducts using in-line precolumn purification.
Mauthe RJ; Marsch GA; Turteltaub KW
J Chromatogr B Biomed Appl; 1996 Apr; 679(1-2):91-101. PubMed ID: 8998575
[TBL] [Abstract][Full Text] [Related]
6. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
Wohlin P; Zeisig M; Gustafsson JA; Möller L
Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
[TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of carcinogen-DNA adducts in exfoliated urothelial cells from 4-aminobiphenyl-treated dogs by 32P-postlabelling and subsequent thin-layer and high-pressure liquid chromatography.
Talaska G; Dooley KL; Kadlubar FF
Carcinogenesis; 1990 Apr; 11(4):639-46. PubMed ID: 2323002
[TBL] [Abstract][Full Text] [Related]
8. Use of the 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis.
Randerath K; Liehr JG; Gladek A; Randerath E
IARC Sci Publ; 1989; (96):189-205. PubMed ID: 2509347
[TBL] [Abstract][Full Text] [Related]
9. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
Reddy MV; Randerath K
Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
[TBL] [Abstract][Full Text] [Related]
10. Formation and persistence of benzo[a]pyrene-DNA adducts in mouse epidermis in vivo: importance of adduct conformation.
Suh M; Ariese F; Small GJ; Jankowiak R; Hewer A; Phillips DH
Carcinogenesis; 1995 Oct; 16(10):2561-9. PubMed ID: 7586167
[TBL] [Abstract][Full Text] [Related]
11. 32P-postlabeling assay for carcinogen-DNA adducts and other dna modifications.
Randerath K; Randerath E
J UOEH; 1989 Mar; 11 Suppl():368-86. PubMed ID: 2664950
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard.
Beland FA; Doerge DR; Churchwell MI; Poirier MC; Schoket B; Marques MM
Chem Res Toxicol; 1999 Jan; 12(1):68-77. PubMed ID: 9894020
[TBL] [Abstract][Full Text] [Related]
13. Fluoranthene-DNA adducts: identification and quantification by an HPLC-32P-postlabeling method.
Gorelick NJ; Wogan GN
Carcinogenesis; 1989 Sep; 10(9):1567-77. PubMed ID: 2670301
[TBL] [Abstract][Full Text] [Related]
14. DNA adduct formation after oral administration of 2-nitrofluorene and N-acetyl-2-aminofluorene, analyzed by 32P-TLC and 32P-HPLC.
Möller L; Zeisig M
Carcinogenesis; 1993 Jan; 14(1):53-9. PubMed ID: 8425271
[TBL] [Abstract][Full Text] [Related]
15. Enhanced sensitivity of 32P-postlabeling analysis of aromatic carcinogen:DNA adducts.
Gupta RC
Cancer Res; 1985 Nov; 45(11 Pt 2):5656-62. PubMed ID: 4053037
[TBL] [Abstract][Full Text] [Related]
16. Monitoring carcinogen actions on DNA by 32P-postlabeling.
Randerath K; Randerath E
Princess Takamatsu Symp; 1990; 21():317-28. PubMed ID: 2134685
[TBL] [Abstract][Full Text] [Related]
17. 32P-postlabeling assay in mice of transplacental DNA damage induced by the environmental carcinogens safrole, 4-aminobiphenyl, and benzo(a)pyrene.
Lu LJ; Disher RM; Reddy MV; Randerath K
Cancer Res; 1986 Jun; 46(6):3046-54. PubMed ID: 3698023
[TBL] [Abstract][Full Text] [Related]
18. 32P-postlabeling analysis of DNA adducts from non-alternant PAH using thin-layer and high performance liquid chromatography.
Weyand EH; Rice JE; LaVoie EJ
Cancer Lett; 1987 Nov; 37(3):257-66. PubMed ID: 3677058
[TBL] [Abstract][Full Text] [Related]
19. Separation of 32P-labelled nucleoside 3',5'-bisphosphate adducts by HPLC.
Pfau W; Lecoq S; Hughes NC; Seidel A; Platt KL; Grover PL; Phillips DH
IARC Sci Publ; 1993; (124):233-42. PubMed ID: 8225490
[TBL] [Abstract][Full Text] [Related]
20. 32P-postlabeling and HPLC separation of DNA adducts formed by diesel exhaust extracts in vitro and in mouse skin and lung after topical treatment.
Savela K; King L; Gallagher J; Lewtas J
Carcinogenesis; 1995 Sep; 16(9):2083-9. PubMed ID: 7554058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
